SynapCell and the University of Utah Celebrate their 10 Year Anniversary of Collaboration on Antiseizure Medications
BioPharma
Source: biopharmadive.com
Epilepsy Therapy Screening Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Epilepsy Therapy Screening Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Epilepsy Therapy Screening Program Today - Breaking & Trending Today
Trevena : Reports Fourth Quarter 2023 Results and Provides Corporate Update - Form 8-K -April 01, 2024 at 06:12 am EDT
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important...
Source: marketscreener.com
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies...
Source: businessinsider.com
Trevena, Inc. (NASDAQ:TRVN) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to Trevena, Inc. Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments
Virpax® Pharmaceuticals, Inc. , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system disorders and viral barrier... -Today at 09:04 am- MarketScreener
Source: marketscreener.com